chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Pyrexia
Clinical narrative: FLU-LIKE SYMPTOMS; MUSCLE PAIN; FATIGUE; FEVER; NAUSEA; HEADACHE; INJECTION SITE PAIN; DIZZINESS; This spontaneous report received from a patient concerned a 41 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient had no known allergies.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. Batch number was not reported and has been requested. No concomitant medications were reported. On 09-APR-2021, the subject experienced dizziness. On 09-APR-2021, the subject experienced headache. On 09-APR-2021, the subject experienced injection site pain. On 09-APR-2021 20:00, the subject experienced flu-like symptoms. On 09-APR-2021 20:00, the subject experienced muscle pain. On 09-APR-2021 20:00, the subject experienced fatigue. On 09-APR-2021 20:00, the subject experienced fever. On 09-APR-2021 20:00, the subject experienced nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from flu-like symptoms, muscle pain, fever, and nausea on 13-APR-2021, and was recovering from fatigue, dizziness, headache, and injection site pain. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: HEADACHE; This spontaneous report received from a consumer concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from headache. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Headache
Clinical narrative: CHEST PAIN; HEADACHE; This spontaneous report received from a patient via a company representative concerned an adult female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported) dose was not reported, administered on 20-MAR-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On 13-APR-2021, the subject experienced chest pain. On 13-APR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from headache, and chest pain. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Axillary pain, Back pain, Magnetic resonance imaging, Muscular weakness
Clinical narrative: BACK PAIN; LOSS OF FEELING IN LEFT POINTER FINGER; LEFT ARMPIT PAIN; WEAKNESS OF LEFT ARM; LEFT ARM PAIN; LEFT SHOULDER PAIN; This spontaneous report received from a patient concerned a 46 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included multiple sclerosis. The patient experienced drug allergy when treated with ciprofloxacin. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805025 expiry: 25-MAY-2021) dose was not reported, administered on 18-MAR-2021 for prophylactic vaccination. Concomitant medications included acetylsalicylic acid, calcium carbonate/colecalciferol, cyanocobalamin, duloxetine hydrochloride, fingolimod hydrochloride, and meloxicam. On 20-MAR-2021, the subject experienced back pain. On 20-MAR-2021, the subject experienced loss of feeling in left pointer finger. On 20-MAR-2021, the subject experienced left armpit pain. On 20-MAR-2021, the subject experienced weakness of left arm. On 20-MAR-2021, the subject experienced left arm pain. On 20-MAR-2021, the subject experienced left shoulder pain. Laboratory data (dates unspecified) included: MRI (NR: not provided) Negative, and Ultrasound joint (NR: not provided) Negative. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from left arm pain, left shoulder pain, back pain, weakness of left arm, loss of feeling in left pointer finger, and left armpit pain. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Sensory loss, Ultrasound joint
Clinical narrative: BACK PAIN; LOSS OF FEELING IN LEFT POINTER FINGER; LEFT ARMPIT PAIN; WEAKNESS OF LEFT ARM; LEFT ARM PAIN; LEFT SHOULDER PAIN; This spontaneous report received from a patient concerned a 46 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included multiple sclerosis. The patient experienced drug allergy when treated with ciprofloxacin. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805025 expiry: 25-MAY-2021) dose was not reported, administered on 18-MAR-2021 for prophylactic vaccination. Concomitant medications included acetylsalicylic acid, calcium carbonate/colecalciferol, cyanocobalamin, duloxetine hydrochloride, fingolimod hydrochloride, and meloxicam. On 20-MAR-2021, the subject experienced back pain. On 20-MAR-2021, the subject experienced loss of feeling in left pointer finger. On 20-MAR-2021, the subject experienced left armpit pain. On 20-MAR-2021, the subject experienced weakness of left arm. On 20-MAR-2021, the subject experienced left arm pain. On 20-MAR-2021, the subject experienced left shoulder pain. Laboratory data (dates unspecified) included: MRI (NR: not provided) Negative, and Ultrasound joint (NR: not provided) Negative. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from left arm pain, left shoulder pain, back pain, weakness of left arm, loss of feeling in left pointer finger, and left armpit pain. This report was non-serious.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Dehydration, Fatigue, Headache, Pain in extremity, SARS-CoV-2 test negative
Clinical narrative: LITTLE HEADACHE; EXHAUSTION; SORENESS IN ARM; DEHYDRATION; This spontaneous report received from a patient concerned a 32 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included migraine, sinus, tension headaches, seasonal allergy, non-alcohol user, and non-smoker, and other pre-existing medical conditions included the patient did had history of marijuana edibles as drug abuse or illicit drug use.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 207A21A, and batch number: 207A21A expiry: UNKNOWN) dose was not reported, administered on 08-APR-2021 11:00 for prophylactic vaccination. Concomitant medications included ibuprofen for tension headache, and rizatriptan benzoate for tension headache. On APR-2021, the subject experienced dehydration. On 08-APR-2021, the subject experienced soreness in arm. On 09-APR-2021, the subject experienced little headache. On 09-APR-2021, the subject experienced exhaustion. Laboratory data (dates unspecified) included: COVID-19 virus test negative (NR: not provided) Negative. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from little headache, and exhaustion on 11-APR-2021, was recovering from soreness in arm, and the outcome of dehydration was not reported. This report was non-serious.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Myalgia, Neck mass, Pain
Clinical narrative: TWO LUMPS ON LEFT SIDE OF NECK; ITCHINESS; PAIN; FATIGUE; FELT FEVER; CHILLS; MILD MUSCLE ACHES; This spontaneous report received from a patient concerned a 35 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A expiry: 21-JUNE-2021) dose was not reported, administered on 10-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 10-APR-2021, the subject experienced chills. On 10-APR-2021, the subject experienced mild muscle aches. On 10-APR-2021, the subject experienced felt fever. Treatment medications included: paracetamol. On 11-APR-2021, the subject experienced fatigue. On 13-APR-2021, the subject experienced two lumps on left side of neck. On 13-APR-2021, the subject experienced itchiness. On 13-APR-2021, the subject experienced pain. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chills, mild muscle aches, and felt fever on 11-APR-2021, and fatigue on 13-APR-2021, had not recovered from two lumps on left side of neck, and the outcome of pain and itchiness was not reported. This report was non-serious.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus, Pyrexia
Clinical narrative: TWO LUMPS ON LEFT SIDE OF NECK; ITCHINESS; PAIN; FATIGUE; FELT FEVER; CHILLS; MILD MUSCLE ACHES; This spontaneous report received from a patient concerned a 35 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A expiry: 21-JUNE-2021) dose was not reported, administered on 10-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 10-APR-2021, the subject experienced chills. On 10-APR-2021, the subject experienced mild muscle aches. On 10-APR-2021, the subject experienced felt fever. Treatment medications included: paracetamol. On 11-APR-2021, the subject experienced fatigue. On 13-APR-2021, the subject experienced two lumps on left side of neck. On 13-APR-2021, the subject experienced itchiness. On 13-APR-2021, the subject experienced pain. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chills, mild muscle aches, and felt fever on 11-APR-2021, and fatigue on 13-APR-2021, had not recovered from two lumps on left side of neck, and the outcome of pain and itchiness was not reported. This report was non-serious.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Chills, Headache, Nausea
Clinical narrative: SHOULDER PAIN; BODY WEAKNESS; CHILLS; HEADACHE; NAUSEA; This spontaneous report received from a patient concerned a 23 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included non smoker, and non alcohol user. The patient experienced drug allergy when treated with codeine. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 043A21A, and batch number: 043A21A expiry: UNKNOWN) dose was not reported, administered on 12-APR-2021 12:00 for prophylactic vaccination. No concomitant medications were reported. On 12-APR-2021, the subject experienced shoulder pain. On 12-APR-2021, the subject experienced body weakness. On 12-APR-2021, the subject experienced chills. On 12-APR-2021, the subject experienced headache. On 12-APR-2021, the subject experienced nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chills, and headache on 13-APR-2021, had not recovered from nausea, and the outcome of shoulder pain and body weakness was not reported. This report was non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Eye contusion, Fall
Clinical narrative: FALL TWICE; BLACK EYE; This spontaneous report received from a consumer concerned a male of unspecified age. The patient's height, and weight were not reported. The patient's concurrent conditions included rare form of msa parkinson, latex allergy, penicillin allergy, and passes out.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 25-MAR-2021 for prophylactic vaccination. Batch number was not reported and has been requested. No concomitant medications were reported. On MAR-2021, the subject experienced black eye. On 25-MAR-2021, the subject experienced fall twice. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the fall twice and black eye was not reported. This report was non-serious. This case, from the same reporter.
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Chills, Dehydration, Hypokinesia, Pain
Clinical narrative: VOMITING/PUKING; LOOKED PALE; BODY ACHES; DEHYDRATION; COULD NOT MOVE PROPERLY; WEAKNESS; CHILLS; FEVER; This spontaneous report received from a patient concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805020, expiry: UNKNOWN) dose was not reported, administered on 11-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On an unspecified date, the subject experienced vomiting/puking, looked pale, body aches, dehydration, could not move properly, weakness, chills, and fever. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the chills, fever, vomiting/puking, looked pale, weakness, body aches, dehydration and could not move properly was not reported. This report was non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Pallor, Pyrexia, Vomiting
Clinical narrative: VOMITING/PUKING; LOOKED PALE; BODY ACHES; DEHYDRATION; COULD NOT MOVE PROPERLY; WEAKNESS; CHILLS; FEVER; This spontaneous report received from a patient concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805020, expiry: UNKNOWN) dose was not reported, administered on 11-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On an unspecified date, the subject experienced vomiting/puking, looked pale, body aches, dehydration, could not move properly, weakness, chills, and fever. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the chills, fever, vomiting/puking, looked pale, weakness, body aches, dehydration and could not move properly was not reported. This report was non-serious.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Computerised tomogram, Diarrhoea, Ear pain, Hypertension, Nodule
Clinical narrative: BUMP ON BUTT; PAIN BEHIND RIGHT EAR; HIGH BLOOD PRESSURE; SORE THROAT; BUMP BEHIND RIGHT EAR; DIARRHEA; This spontaneous report received from a patient. The patient's height, and weight were not reported. The patient's concurrent conditions included high blood pressure, and acid reflux. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805031, expiry: UNKNOWN) dose was not reported, administered on 12-MAR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 14-MAR-2021, the subject experienced diarrhea. On 26-MAR-2021, the subject experienced bump behind right ear. On 26-MAR-2021, the subject experienced sore throat. On APR-2021, Laboratory data included: CAT scan (NR: not provided) Unknown. On 05-APR-2021, the subject experienced pain behind right ear. On 05-APR-2021, the subject experienced high blood pressure. On 14-APR-2021, the subject experienced bump on butt. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from high blood pressure on 06-APR-2021, and had not recovered from pain behind right ear, diarrhea, bump behind right ear, bump on butt, and sore throat. This report was non-serious.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Rash
Clinical narrative: BUMP ON BUTT; PAIN BEHIND RIGHT EAR; HIGH BLOOD PRESSURE; SORE THROAT; BUMP BEHIND RIGHT EAR; DIARRHEA; This spontaneous report received from a patient. The patient's height, and weight were not reported. The patient's concurrent conditions included high blood pressure, and acid reflux. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805031, expiry: UNKNOWN) dose was not reported, administered on 12-MAR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 14-MAR-2021, the subject experienced diarrhea. On 26-MAR-2021, the subject experienced bump behind right ear. On 26-MAR-2021, the subject experienced sore throat. On APR-2021, Laboratory data included: CAT scan (NR: not provided) Unknown. On 05-APR-2021, the subject experienced pain behind right ear. On 05-APR-2021, the subject experienced high blood pressure. On 14-APR-2021, the subject experienced bump on butt. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from high blood pressure on 06-APR-2021, and had not recovered from pain behind right ear, diarrhea, bump behind right ear, bump on butt, and sore throat. This report was non-serious.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Myalgia
Clinical narrative: JOINT PAIN; HEAVY MUSCLE ACHES; This spontaneous report received from a patient concerned a 35 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A expiry: UNKNOWN) dose was not reported, administered on 13-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 13-APR-2021, the subject experienced joint pain. On 13-APR-2021, the subject experienced heavy muscle aches. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from heavy muscle aches, and joint pain. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Headache
Clinical narrative: FELT EXTREMELY HOT; BAD HEADACHE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: UNKNOWN) dose was not reported, administered on 12-APR-2021 for prophylactic vaccination. The batch number was not reported and it has been requested. No concomitant medications were reported.  On APR-2021, the subject experienced felt extremely hot. On APR-2021, the subject experienced bad headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from bad headache, and felt extremely hot. This report was non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Coccydynia, Pain, Pyrexia
Clinical narrative: TAILBONE SORENESS; BODY ACHES; ANKLE SORENESS; SLIGHT TEMPERATURE; This spontaneous report received from a consumer concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 12-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On APR-2021, the subject experienced tailbone soreness. On APR-2021, the subject experienced body aches. On APR-2021, the subject experienced ankle soreness. On APR-2021, the subject experienced slight temperature. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the slight temperature, ankle soreness, tailbone soreness and body aches was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Discomfort, Fatigue, Headache, Pain
Clinical narrative: BODY PAIN; BODY HEAVINESS; FELT TIREDNESS; HEADACHE; This spontaneous report received from a patient via a company representative concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: UNKWON) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported, per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the subject experienced body pain, body heaviness, felt tiredness, and headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the felt tiredness, headache, body pain and body heaviness was not reported. This report was non-serious.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: SORE ARM; This spontaneous report received from a consumer concerned a 59 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported) dose was not reported, administered on 06-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 06-APR-2021, the subject experienced sore arm. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from sore arm on 08-APR-2021. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Back pain, No adverse event
Clinical narrative: BLOOD CLOTS; BACKACHE/BACK PAIN; This spontaneous report received from a patient concerned a 72 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included backache. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. Concomitant medications included oxycodone for backache/back pain.  On MAR-2021, the subject experienced blood clots. On MAR-2021, the subject experienced backache/back pain. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from blood clots, and the outcome of backache/back pain was not reported. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Chills, Constipation, Neck pain, Pain in extremity, Pyrexia
Clinical narrative: CONSTIPATION; SORE NECK; TENDER ANKLE; LEG PAIN; CHILLS; FEVER; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced constipation, sore neck, tender ankle, leg pain, chills, and fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the leg pain, constipation, fever, chills, sore neck and tender ankle was not reported. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Eye pain, Headache, Visual impairment
Clinical narrative: PAIN ON LEFT EYEBALL; CAN'T HARDLY SEE; HEADACHE; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, the subject experienced pain on left eyeball, can't hardly see, and headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the headache, pain on left eyeball and can't hardly see was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: INJECTION SITE SORENESS; This spontaneous report received from a consumer concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, the subject experienced injection site soreness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of injection site soreness was not reported. This report was non-serious.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Fatigue, Headache, Pyrexia
Clinical narrative: SEVERE HEADACHE; FEVER; TIRED; This spontaneous report received from a consumer concerned a 43 year old female. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 204A21A, and expiry: 23-JUN-2021) dose was not reported, administered on 12-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, treatment medications included: ibuprofen. On 12-APR-2021, the subject experienced severe headache. On 12-APR-2021, the subject experienced fever. On 12-APR-2021, the subject experienced tired. Laboratory data included: Body temperature (NR: not provided) 102 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from fever, and had not recovered from severe headache, and tired. This report was non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Oropharyngeal discomfort
Clinical narrative: FEELING WEIRD SENSATION IN THROAT; This spontaneous report received from a patient concerned a male of unspecified age. The patient's height, and weight were not reported. The patient's concurrent conditions included alcohol user, and smoker, and other pre-existing medical conditions included the patient had no known drug allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 041A21A, and expiry: UNKNOWN) dose was not reported, administered on 13-APR-2021 for prophylactic vaccination.  Concomitant medications included orlistat. On 13-APR-2021 13:00, the subject experienced feeling weird sensation in throat. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from feeling weird sensation in throat. This report was non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Fatigue, Headache, Neck pain, Pain
Clinical narrative: ACHES; BACK ACHE; NECK ACHE; HEADACHE; FATIGUE; This spontaneous report received from a consumer via a company representative concerned a male of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case.  No concomitant medications were reported. On an unspecified date, the subject experienced aches, back ache, neck ache, headache, and fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from aches, headache, fatigue, back ache, and neck ache. This report was non-serious.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Laboratory test, Myalgia, Pyrexia
Clinical narrative: HEADACHE; LOW GRADE FEVER; MUSCLE ACHES; TIREDNESS; This spontaneous report received from a patient concerned a 70 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included high blood pressure, glaucoma, non alcoholic, and non smoker, and other pre-existing medical conditions included patient had no known drug allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported and batch number: 206A21A expiry: UNKNOWN) dose was not reported, administered on 12-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 13-APR-2021, the subject experienced headache. On 13-APR-2021, the subject experienced low grade fever. On 13-APR-2021, the subject experienced muscle aches. On 13-APR-2021, the subject experienced tiredness. Laboratory data (dates unspecified) included: Lab test (NR: not provided) Normal. Treatment medications (dates unspecified) included: acetylsalicylic acid/caffeine/paracetamol/salicylamide. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from headache, low grade fever, and tiredness, and had not recovered from muscle aches. This report was non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Influenza like illness
Clinical narrative: FLU-LIKE SYMPTOMS; This spontaneous report received from a patient concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the subject experienced flu-like symptoms. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of flu-like symptoms was not reported. This report was non-serious. This case, from the same reporter is linked to 20210420609.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Pain in extremity, Paraesthesia
Clinical narrative: TINGLING OF FINGER TIPS OF LEFT HAND; HEADACHE; TIRED; ARM PAIN; This spontaneous report received from a patient concerned a 62 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included cat allergy, alcohol user, and smoker, and other pre-existing medical conditions included the patient had no any drug abuse or illicit drug usage and other pre-existing medical conditions included nothing significant. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 041A21A expiry: UNKNOWN) dose was not reported, administered on 07-APR-2021 for prophylactic vaccination. Concomitant medications included minerals nos/vitamins nos.  On 07-APR-2021, the subject experienced arm pain. Treatment medications included: Tylenol (paracetamol). On 08-APR-2021, the subject experienced headache. On 08-APR-2021, the subject experienced tired. On 09-APR-2021, the subject experienced tingling of finger tips of left hand. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from tingling of finger tips of left hand on 09-APR-2021, arm pain on 08-APR-2021, headache on 10-APR-2021, and tired on 11-APR-2021. This report was non-serious.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Nausea, Pyrexia
Clinical narrative: CHILLS; HEADACHE; FEVER; NAUSEA; This spontaneous report received from a patient concerned a 19 year old female. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 29-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested.  No concomitant medications were reported. On 30-MAR-2021, the subject experienced chills. On 30-MAR-2021, the subject experienced headache. On 30-MAR-2021, the subject experienced fever. On 30-MAR-2021, the subject experienced nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the headache, chills, fever and nausea was not reported. This report was non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Nausea
Clinical narrative: NAUSEA; This spontaneous report received from a consumer concerned a male of unspecified age. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported and batch number: 043A21A expiry: UNKNOWN) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 11-APR-2021, the subject experienced nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from nausea. This report was non-serious.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Injection site pain, Pain, Pain in extremity
Clinical narrative: DIZZY; LIGHTHEADEDNESS; PAIN UNDER THE LEFT ARM; CHILLS; SORENESS AT INJECTION SITE; FEVER; GENERALIZED ACHING; This spontaneous report received from a patient concerned a 28 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient does not have any allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 041A21A expiry: UNKNOWN) dose was not reported, administered on 10-APR-2021 01:30 for prophylactic vaccination. No concomitant medications were reported.  On 10-APR-2021, the subject experienced generalized aching. On 10-APR-2021, the subject experienced soreness at injection site. On 10-APR-2021, the subject experienced fever. On 11-APR-2021, the subject experienced chills. On 13-APR-2021, the subject experienced dizzy. On 13-APR-2021, the subject experienced lightheadedness. On 13-APR-2021, the subject experienced pain under the left arm. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from generalized aching on 12-APR-2021, chills on 11-APR-2021, soreness at injection site on 10-APR-2021, and fever on 13-APR-2021, and was recovering from dizzy, lightheadedness, and pain under the left arm. This report was non-serious.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: DIZZY; LIGHTHEADEDNESS; PAIN UNDER THE LEFT ARM; CHILLS; SORENESS AT INJECTION SITE; FEVER; GENERALIZED ACHING; This spontaneous report received from a patient concerned a 28 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient does not have any allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 041A21A expiry: UNKNOWN) dose was not reported, administered on 10-APR-2021 01:30 for prophylactic vaccination. No concomitant medications were reported.  On 10-APR-2021, the subject experienced generalized aching. On 10-APR-2021, the subject experienced soreness at injection site. On 10-APR-2021, the subject experienced fever. On 11-APR-2021, the subject experienced chills. On 13-APR-2021, the subject experienced dizzy. On 13-APR-2021, the subject experienced lightheadedness. On 13-APR-2021, the subject experienced pain under the left arm. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from generalized aching on 12-APR-2021, chills on 11-APR-2021, soreness at injection site on 10-APR-2021, and fever on 13-APR-2021, and was recovering from dizzy, lightheadedness, and pain under the left arm. This report was non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: HIVES AND RED SPOTS ALL OVER BODY, DESCRIBED AS REACTION; This spontaneous report received from a patient via a company representative concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 2021, the subject experienced hives and red spots all over body, described as reaction. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of hives and red spots all over body, described as reaction was not reported. This report was non-serious.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Back pain, Chills, Headache
Clinical narrative: GENERALISED ACHING; CHILLS; FEVER ON SATURDAY NIGHT; HEADACHE; FEELING WEAK; PAIN IN KNEES ALTERNATING; PAIN IN RIBS; PAIN IN BACK; PAIN IN LEGS GOING TOWARDS TOES ALTERNATING BETWEEN LEGS; This spontaneous report received from a patient concerned a 42 year old female. The patient's height, and weight were not reported. The patient's past medical history included covid-19 infection.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular and batch number: 203A21A expiry: UNKNOWN) dose was not reported, administered on 10-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On APR-2021, the subject experienced pain in ribs. On APR-2021, the subject experienced pain in back. On APR-2021, the subject experienced pain in legs going towards toes alternating between legs. On APR-2021, the subject experienced feeling weak. On APR-2021, the subject experienced pain in knees alternating. On 10-APR-2021, the subject experienced generalised aching. On 10-APR-2021, the subject experienced chills. On 10-APR-2021, the subject experienced fever on saturday night. On 10-APR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from headache, generalised aching, pain in ribs, pain in back, pain in legs going towards toes alternating between legs, and pain in knees alternating, and the outcome of fever on saturday night, chills and feeling weak was not reported. This report was non-serious.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Musculoskeletal chest pain, Pain, Pain in extremity, Pyrexia
Clinical narrative: GENERALISED ACHING; CHILLS; FEVER ON SATURDAY NIGHT; HEADACHE; FEELING WEAK; PAIN IN KNEES ALTERNATING; PAIN IN RIBS; PAIN IN BACK; PAIN IN LEGS GOING TOWARDS TOES ALTERNATING BETWEEN LEGS; This spontaneous report received from a patient concerned a 42 year old female. The patient's height, and weight were not reported. The patient's past medical history included covid-19 infection.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular and batch number: 203A21A expiry: UNKNOWN) dose was not reported, administered on 10-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On APR-2021, the subject experienced pain in ribs. On APR-2021, the subject experienced pain in back. On APR-2021, the subject experienced pain in legs going towards toes alternating between legs. On APR-2021, the subject experienced feeling weak. On APR-2021, the subject experienced pain in knees alternating. On 10-APR-2021, the subject experienced generalised aching. On 10-APR-2021, the subject experienced chills. On 10-APR-2021, the subject experienced fever on saturday night. On 10-APR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from headache, generalised aching, pain in ribs, pain in back, pain in legs going towards toes alternating between legs, and pain in knees alternating, and the outcome of fever on saturday night, chills and feeling weak was not reported. This report was non-serious.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site bruising, Pain, Pain in extremity, Peripheral swelling
Clinical narrative: BRUISED PURPLE SPOTS AROUND INJECTION SITE; BODY ACHES; LEFT ARM SWELLING; LEFT ARM SORENESS; This spontaneous report received from a patient concerned a 54 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included asthma, diabetes, non smoker, and non alcohol user, and other pre-existing medical conditions included the patient had no drug or non-drug allergies. the patient did not have any history of drug abuse or illicit drug use. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 1805029 expiry: UNKNOWN) dose was not reported, administered on 29-MAR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 30-MAR-2021, the subject experienced left arm swelling. On 30-MAR-2021, the subject experienced left arm soreness. On 31-MAR-2021, the subject experienced body aches. On 05-APR-2021, the subject experienced bruised purple spots around injection site. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from bruised purple spots around injection site, and had not recovered from left arm soreness, body aches, and left arm swelling. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Malaise
Clinical narrative: FELT SICK/FEELING UNWELL; This spontaneous report received from a consumer concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 07-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced felt sick/feeling unwell. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of felt sick/feeling unwell was not reported. This report was non-serious.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Body temperature, Chills, Injection site bruising, Injection site reaction
Clinical narrative: RED BRUISE ON LEFT ARM; INJECTION SITE WARMNESS; TINGLING SENSATION IN LEFT LEG; INJECTION SITE BULGING; INJECTION SITE REDNESS; LEFT ARM PAIN; FEVER; WEAKNESS; CHILLS; This spontaneous report received from a patient concerned a 40 year old female. The patient's height, and weight were not reported. The patient's past medical history included gluten allergy, and other pre-existing medical conditions included the patient was not pregnant at the time of reporting. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805029, expiry: UNKNOWN) dose was not reported, administered on 10-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 11-APR-2021, the subject experienced chills. On 11-APR-2021, the subject experienced fever. On 11-APR-2021, the subject experienced weakness. Laboratory data included: Body temperature (NR: not provided) 101 F. Treatment medications included: paracetamol. On 12-APR-2021, the subject experienced red bruise on left arm. On 12-APR-2021, the subject experienced injection site warmness. On 12-APR-2021, the subject experienced tingling sensation in left leg. On 12-APR-2021, the subject experienced injection site bulging. On 12-APR-2021, the subject experienced injection site redness. On 12-APR-2021, the subject experienced left arm pain. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chills, and fever on 11-APR-2021, and weakness on 12-APR-2021, and had not recovered from red bruise on left arm, injection site warmness, tingling sensation in left leg, left arm pain, injection site bulging, and injection site redness. This report was non-serious.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site swelling, Injection site warmth, Pain in extremity, Paraesthesia, Pyrexia
Clinical narrative: RED BRUISE ON LEFT ARM; INJECTION SITE WARMNESS; TINGLING SENSATION IN LEFT LEG; INJECTION SITE BULGING; INJECTION SITE REDNESS; LEFT ARM PAIN; FEVER; WEAKNESS; CHILLS; This spontaneous report received from a patient concerned a 40 year old female. The patient's height, and weight were not reported. The patient's past medical history included gluten allergy, and other pre-existing medical conditions included the patient was not pregnant at the time of reporting. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805029, expiry: UNKNOWN) dose was not reported, administered on 10-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 11-APR-2021, the subject experienced chills. On 11-APR-2021, the subject experienced fever. On 11-APR-2021, the subject experienced weakness. Laboratory data included: Body temperature (NR: not provided) 101 F. Treatment medications included: paracetamol. On 12-APR-2021, the subject experienced red bruise on left arm. On 12-APR-2021, the subject experienced injection site warmness. On 12-APR-2021, the subject experienced tingling sensation in left leg. On 12-APR-2021, the subject experienced injection site bulging. On 12-APR-2021, the subject experienced injection site redness. On 12-APR-2021, the subject experienced left arm pain. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chills, and fever on 11-APR-2021, and weakness on 12-APR-2021, and had not recovered from red bruise on left arm, injection site warmness, tingling sensation in left leg, left arm pain, injection site bulging, and injection site redness. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nausea, Pain
Clinical narrative: BODY ACHE; SEVERE HEADACHE; NAUSEA; This spontaneous report received from a consumer concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 05-APR-2021 for prophylactic vaccination. The batch number was not reported. The company was unable to perform follow up to request batch/lot numbers. No concomitant medications were reported. On 05-APR-2021, the subject experienced body ache. On 05-APR-2021, the subject experienced severe headache. On 05-APR-2021, the subject experienced nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from severe headache, body ache, and nausea. This report was non-serious.